Sign in
Skills³ coordination office
Interface Entreprises-Université
LIEGE science park
Avenue Pré-Aily, 4 (B60)
B- 4031 Angleur
Interface Entreprises-Université
LIEGE science park
Avenue Pré-Aily, 4 (B60)
B- 4031 Angleur
GlaxoSmithKline Biologicals
Print this company profile
Rue de l'Institut
1330 Rixensart
Belgium
T 0032-2 -6568111
F 0032-2-6568000
W http://www.gsk-bio.com
Mr. David Van Cauwenberg
david.van-cauwenberg@gskbio.com
Staff Specialties:
All the various functions in this field - overall strategy, research and development, clinical development, regulatory matters, production, quality assurance/control, marketing and supply chain & distribution to every corner of the world - are integrated or coordinated from its global Headquarter in Rixensart, South of Brussels in Belgium.
Headquartered in Belgium, GSK Biologicals employs over 9 000 people worldwide (6000 in Belgium) including more than 1 600 passionate scientists engaged in research aimed at discovering innovative vaccines that contribute to the health and well-being of people of all generations around the world.
Profit
Company
Company
1000+ employees
Activities:
- Drugs and therapeutics
- Clinical research/medical testing
Print this company profile
Contact
GlaxoSmithKline BiologicalsRue de l'Institut
1330 Rixensart
Belgium
T 0032-2 -6568111
F 0032-2-6568000
W http://www.gsk-bio.com
HR Info
HR contact:Mr. David Van Cauwenberg
david.van-cauwenberg@gskbio.com
Staff Specialties:
All the various functions in this field - overall strategy, research and development, clinical development, regulatory matters, production, quality assurance/control, marketing and supply chain & distribution to every corner of the world - are integrated or coordinated from its global Headquarter in Rixensart, South of Brussels in Belgium.
Company Description
GlaxoSmithKline Biologicals is one of the world's leading vaccine producer and the fastest growing business within the GSK group today. The company is active in the fields of vaccine research, development and production with over 30 vaccines approved for marketing and 20 more in development. In 2008 GSK Bio distributed 1.1 billion doses of vaccines to 176 countries in both developed and the developing world an average of 3 million doses a day. Headquartered in Belgium, GSK Biologicals employs over 9 000 people worldwide (6000 in Belgium) including more than 1 600 passionate scientists engaged in research aimed at discovering innovative vaccines that contribute to the health and well-being of people of all generations around the world.
